Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load

J Clin Oncol. 2010 Jul 20;28(21):e355-6; author reply e357. doi: 10.1200/JCO.2010.28.4604. Epub 2010 May 10.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacokinetics*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Radioisotopes
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab
  • Zirconium

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Radioisotopes
  • Zirconium
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab